Results per Page:
A new immune strategy to keep multiple myeloma at bay
From the Hill Lab, Translational Science and Therapeutics Division
Un triplete de fármacos prolonga la supervivencia sin progresión en el cáncer de mama avanzado
Del equipo de oncología mamaria del Departamento de Investigaciones Clínicas y el grupo de estudio VIKTORIA-1
Tumor suppressors gone rogue: a new class of targets for TCR-based cell therapies
From the Chapuis and Greenberg Labs, Translational Science and Therapeutics Division
A triplet of drugs extends progression-free survival in advanced breast cancer
From the Breast Oncology Team, Clinical Research Division, and the VIKTORIA-1 study group
A COVID-19 Antiviral, Reconsidered: What modeling reveals about Molnupiravir
From the Schiffer Lab, Vaccine and Infectious Disease Division
A promising new antibody treatment for a neglected respiratory virus
From the Boonyaratanakornkit Lab, Vaccine and Infectious Disease Division
Space Invaders: Extracellular bacterial occupation alters tumor fate
From the Bullman Lab, Human Biology Division
A new high-throughput method for flu vaccine strain selection
From the Bloom Lab, Basic Sciences Division
More than nutrition: How breast milk IgG trains infant immunity
From the Koch Lab, Basic Sciences Division
Guiding the attack: CXCR3 leads CAR T cells to pediatric brain tumors
From the Vitanza Lab, Seattle Children’s Research Institute, University of Washington and the Cancer Consortium
From Data to Diagnosis: GREGoR aims to demystify rare diseases
From the Genomics Research to Elucidate the Genetics of Rare Diseases (GREGoR) Consortium, including the Fred Hutch/University of Washington/Seattle Children’s Cancer Consortium
Rebuilding a stem cell incubator: a fetal liver co-culture fosters the rarest blood cells
From the Hadland Lab, Translational Science and Therapeutics Division
(TGF)Bait and Switch: Rewiring suppression into T cell power
From the Greenberg Lab, Translational Science and Therapeutics Division